Ad hoc announcements pursuant to Art. 53 LR

Results of Accelerated Bookbuild Offering of 1,500,000 Existing Shares in PolyPeptide Group AG

10 Nov 2021 - PolyPeptide Group / Key word(s): Transaction in Own Shares Results of Accelerated Bookbuild Offering of 1,500,000 Existing Shares in PolyPeptide Group AG 10-Nov-2021 / 07:15 CET/CEST […]

Read more
Media releases

PolyPeptide customer Cara Therapeutics with FDA approval for novel treatment of moderate-to-severe pruritus in hemodialysis patients

1 Sep 2021 - Long-term collaborative development process for peptide API successfully completed and continued with commercial supply agreement Zug, 1 September 2021 – PolyPeptide is pleased to announce that […]

Read more
Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide reports strong H1 2021 revenue growth and operating leverage amidst favorable market environment and encouraging business trends

17 Aug 2021 - PolyPeptide Group / Key word(s): Half Year Results PolyPeptide reports strong H1 2021 revenue growth and operating leverage amidst favorable market environment and encouraging business trends […]

Read more
Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide Group appoints Christina Del Vecchio as General Counsel and member of the Executive Committee

25 Jun 2021 - PolyPeptide Group / Key word(s): Personnel PolyPeptide Group appoints Christina Del Vecchio as General Counsel and member of the Executive Committee 25-Jun-2021 / 07:00 CET/CEST Release […]

Read more
Business news

Proclamation honoring Jane Salik upon her retirement

11 May 2021 - The city of Torrance, California, honored Jane Salik for her investment in the Torrance community and her outstanding contributions to the Science and Peptide Industry. 05-11-21 […]

Read more
Ad hoc announcements pursuant to Art. 53 LR

PolyPeptide Group announces the exercise of the full over-allotment option

5 May 2021 - NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY […]

Read more
Business news

Stock Exchange Listing

29 Apr 2021 - What an exhilarating day! Today the PolyPeptide Group became a public company. Our shares began trading on SIX, the Swiss Stock Exchange. Our entire Executive Committee was […]

Read more
Media releases

PolyPeptide Group appoints Raymond De Vré as new Chief Executive Officer

16 Feb 2021 - Feb 16, 2021 7:00 AM PolyPeptide Group, a global leader in peptide manufacturing and development, today announced the appointment of Dr. Raymond De Vré as its […]

Read more
Business news

PolyPeptide News Flash, #1, 2021

28 Jan 2021 - PolyPeptide Group maintained a strong and healthy pipeline that has gained a significant growth in 2020. This growth in Pipeline Projects reflects the growth in peptide […]

Read more